• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 AXIUM PRIME BRPL 3D; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 AXIUM PRIME BRPL 3D; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION Back to Search Results
Model Number APB-5-15-3D-SS
Medical Device Problem Codes Detachment of Device or Device Component (2907); Migration (4003)
Health Effect - Clinical Code Obstruction/Occlusion (2422)
Date of Event 02/21/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
Medtronic received information that an axium coil detached prematurely in the microcatheter and it migrated into the middle cerebral artery, causing an occlusion.The patient was being treated form a ruptured saccular aneurysm in the left internal carotid artery.The max diameter was 8mm and the neck diameter was 6mm.Patient blood flow was normal and vessel tortuosity was moderate. while attempting to place this axium coil, the microcatheter kicked out of the aneurysm.The physician rode the microcatheter over the coil to re-enter the aneurysm.Once back inside the aneurysm he noticed the coil was not moving with multiple attempts to advance or withdraw.He then noticed the coil had detached from the microcatheter early.An attempt was made with a tulip snare to snare the coil but this was unsuccessful and the coil migrated into the middle cerebral artery, causing an occlusion.A solitaire was then deployed across the coil and retracted into a guide catheter under aspiration to successfully remove the coil from the patient.The coil was removed from the patient with a solitaire. coil was removed via a solitaire and patient was placed on blood thinners due to the occlusion the coil was causing.Surgical intervention was required.The pushwire was no bent or broken.There was no friction or difficulty during the delivery.The physician repositioned the coil two times.The physician did not attempt to detach the coil.The physician did not attempt to detach the coil.The delivery pusher was not rotated during the procedure.Continuous flush was administered during the procedure. ancillary devices: stryker sl-10 microcatheter, penumbra benchmark guide catheter.
 
Additional Manufacturer Narrative
B5.Updated with additional information received.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
Additional information received reported no additional intervention was required after the detach coil was successfully retrieved and removed with the solitaire.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIUM PRIME BRPL 3D
Common Device Name
DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key13866723
Report Number2029214-2022-00463
Device Sequence Number4692905
Product Code KRD
UDI-Device Identifier00847536008212
UDI-Public00847536008212
Combination Product (Y/N)N
Initial Reporter StateMI
Initial Reporter CountryUS
PMA/510(K) Number
K081465
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/12/2024
Device Model NumberAPB-5-15-3D-SS
Device Catalogue NumberAPB-5-15-3D-SS
Device Lot Number221882791
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/23/2022
Supplement Date Received by Manufacturer05/23/2022
Initial Report FDA Received Date03/23/2022
Supplement Report FDA Received Date05/25/2022
Date Device Manufactured03/12/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other; Required Intervention;
Patient SexFemale
-
-